Expression of concern regarding the notice of retraction of the article "Hydroxychloroquine and azithromycin as a treatment for COVID-19: results from an open-label, non-randomized clinical trial.
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
In January 2025, a notice of retraction of the article that reported in a preliminary prospective clinical trial and for the first time, a better clearance of the SARS-CoV2 viral load in patients treated for at least 3 days with 200 mg three times a day of Hydroxychloroquine was published. Here is a point-by-point response to this retraction notice so that the reader can make up his own mind in a spirit of open science.
